Semaglutide may reduce Alzheimer’s risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. Researchers at Case Western Reserve School of Medicine have found that semaglutide, a popular drug used for both diabetes and weight loss, may reduce the risk of Alzheimer’s disease in people with type 2 […]
Source link